Sagimet Biosciences Investors

16 investors on Angel Roster list Sagimet Biosciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Hong Kong and China.

Investors are matched on the company name in their portfolio, so companies that share the name Sagimet Biosciences can appear together.

Investors listed
16
With verified email
38%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Sagimet Biosciences investors

The most complete profiles first. Showing 16 of 16.

  • Beth SeidenbergVerified

    Venture Capital, Incubator, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Atara Biotherapeutics, ACELYRIN, iPierian, Mango Health and 16 more

    Verified email available

  • David GoeddelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Peter SvennilsonVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • John DoerrVerified

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Verified email available

  • Josh CoyneVerified

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Verified email available

  • Annie Case

    Venture Capital, Investor · United States

    Series BWearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 85 more

    Contact details available

  • Tim Kutzkey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • JJ Kang

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • James Evangelista

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Nikki Zhang

    Venture Capital · China

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Susan Biglieri

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Sagimet Biosciences investors are on Angel Roster?

Angel Roster lists 16 Sagimet Biosciences investors. 6 of them (38%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (7) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Sagimet Biosciences investors invest in?

Among those that list a stage, the most common are Seed (3) and Series B (2).

Where are Sagimet Biosciences investors based?

Most are based in the United States (10), Hong Kong (2) and China (1).

Which companies have Sagimet Biosciences investors backed?

The most-backed portfolio companies among them are Vera Therapeutics (6), TESARO (6), Flexus Biosciences (6), Neuron23 (6) and ArsenalBio (6).

How do I contact Sagimet Biosciences investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.